Apparently, this post was lost in the transition to the new blogging application (which took place May 15-22). The FDA earlier this month announced plans to increase field testing and other inspection of imported food and pharma goods in response to the recent salmonella and drug scares.

The FDA budget document states:

“In the complex and rapidly changing environment driven by globalisation, FDA cannot rely on traditional approaches – inspection and sampling at the US border – to protect Americans and ensure the safety of medical products. FDA will use traditional and innovative mechanisms that include FDA inspections and field exams, integrated federal-state oversight, and greater access to inspection data and results acquired from trusted foreign regulatory authorities.”

The plans include a more than 100% increase in the number of field tests of imported drugs, and a boost in the inspections of high-risk foreign and domestic facilities by nearly 20%.

See the overview article at:

http://www.in-pharmatechnologist.com/Industry-Drivers/FDA-requests-19-funding-boost-to-secure-supply-chain/?c=JiBz%2FX6W896enue4TQ%2BDEw%3D%3D&utm_source=newsletter_daily&utm_medium=email&utm_campaign=Newsletter%2BDaily

Cheers, Steve